Koninklijke Philips Return on Investment 2012-2026 | PHG
Current and historical return on investment (ROI) values for Koninklijke Philips (PHG) over the last 10 years.
| Koninklijke Philips ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-06-30 | $1.98B | $20.81B | 9.54% |
| 2026-03-31 | $1.73B | $20.63B | 8.39% |
| 2025-12-31 | $1.61B | $20.22B | 7.97% |
| 2025-09-30 | $1.38B | $15.15B | 9.08% |
| 2025-06-30 | $1.87B | $15.07B | 12.40% |
| 2025-03-31 | $1.66B | $15.35B | 10.79% |
| 2024-09-30 | $0.87B | $10.40B | 8.34% |
| 2024-06-30 | $0.51B | $16.14B | 3.14% |
| 2023-06-30 | $-0.27B | $16.39B | -1.65% |
| 2023-03-31 | $-0.26B | $15.99B | -1.63% |
| 2022-06-30 | $0.76B | $20.68B | 3.66% |
| 2021-06-30 | $1.10B | $19.54B | 5.64% |
| 2020-06-30 | $1.28B | $18.65B | 6.85% |
| 2019-06-30 | $1.93B | $18.63B | 10.34% |
| 2018-06-30 | $2.07B | $18.77B | 11.04% |
| 2017-06-30 | $2.14B | $19.15B | 11.18% |
| 2016-12-31 | $2.08B | $18.90B | 11.02% |
| 2016-09-30 | $1.36B | $18.46B | 7.37% |
| 2016-06-30 | $1.20B | $17.95B | 6.71% |
| 2016-03-31 | $1.17B | $17.27B | 6.74% |
| 2015-12-31 | $1.10B | $17.44B | 6.32% |
| 2015-09-30 | $0.93B | $17.91B | 5.17% |
| 2015-06-30 | $0.42B | $18.43B | 2.30% |
| 2015-03-31 | $0.49B | $18.96B | 2.60% |
| 2014-12-31 | $0.65B | $19.46B | 3.32% |
| 2014-09-30 | $1.61B | $19.41B | 8.27% |
| 2014-06-30 | $2.34B | $19.32B | 12.12% |
| 2014-03-31 | $2.55B | $19.15B | 13.32% |
| 2013-12-31 | $2.65B | $19.11B | 13.84% |
| 2013-09-30 | $1.78B | $19.08B | 9.32% |
| 2013-06-30 | $1.91B | $19.31B | 9.88% |
| 2013-03-31 | $1.45B | $19.88B | 7.29% |
| 2012-12-31 | $1.63B | $20.34B | 8.02% |
| 2012-09-30 | $1.50B | $21.00B | 7.14% |
| 2012-06-30 | $0.95B | $21.64B | 4.41% |
| 2012-03-31 | $1.08B | $22.09B | 4.90% |
| 2011-12-31 | $1.33B | $22.51B | 5.90% |
| 2011-09-30 | $2.35B | $23.00B | 10.22% |
| 2011-06-30 | $2.78B | $23.38B | 11.90% |
| 2011-03-31 | $2.97B | $23.71B | 12.51% |
| 2010-12-31 | $2.66B | $24.27B | 10.96% |
| 2010-09-30 | $3.94B | $24.68B | 15.96% |
| 2010-06-30 | $3.71B | $24.75B | 15.01% |
| 2010-03-31 | $2.13B | $24.55B | 8.67% |
| 2009-12-31 | $1.35B | $24.45B | 5.52% |
| 2009-09-30 | $-0.97B | $25.33B | -3.81% |
| 2009-06-30 | $-1.42B | $27.33B | -5.20% |
| 2009-03-31 | $-0.01B | $30.16B | -0.03% |
| 2008-12-31 | $0.52B | $32.72B | 1.60% |
| 2008-09-30 | $1.46B | $33.33B | 4.39% |
| 2008-06-30 | $1.99B | $32.82B | 6.08% |
| 2008-03-31 | $2.07B | $32.07B | 6.44% |
| 2007-12-31 | $2.11B | $31.46B | 6.71% |
| 2007-09-30 | $4.74B | $31.78B | 14.92% |
| 2007-06-30 | $4.28B | $32.78B | 13.04% |
| 2007-03-31 | $4.28B | $32.15B | 13.31% |
| 2006-12-31 | $4.27B | $31.27B | 13.65% |
| 2006-09-30 | $1.85B | $29.33B | 6.31% |
| 2006-06-30 | $2.33B | $26.77B | 8.69% |
| 2006-03-31 | $2.71B | $25.59B | 10.59% |
| 2005-12-31 | $2.77B | $24.19B | 11.45% |
| 2005-09-30 | $5.05B | $24.20B | 20.87% |
| 2005-06-30 | $4.95B | $23.99B | 20.62% |
| 2005-03-31 | $4.50B | $23.42B | 19.21% |
| 2004-12-31 | $4.40B | $23.04B | 19.09% |
| 2004-09-30 | $-1.59B | $22.15B | -7.19% |
| 2004-06-30 | $-1.90B | $21.32B | -8.91% |
| 2004-03-31 | $-2.31B | $21.00B | -11.01% |
| 2003-12-31 | $-2.56B | $20.73B | -12.35% |
| 2003-09-30 | $-2.37B | $20.74B | -11.41% |
| 2003-06-30 | $-2.37B | $21.61B | -10.96% |
| 2003-03-31 | $-2.77B | $22.37B | -12.40% |
| 2002-12-31 | $-2.78B | $22.87B | -12.16% |
| 2002-09-30 | $-20.82B | $23.07B | -90.27% |
| 2002-06-30 | $-14.67B | $17.25B | -85.07% |
| 2002-03-31 | $-7.65B | $11.27B | -67.82% |
| 2001-12-31 | $-0.19B | $5.55B | -3.33% |
| 2001-09-30 | $-2.65B | $5.61B | -47.18% |
| 2001-06-30 | $-0.37B | $5.61B | -6.63% |
| 2001-03-31 | $1.62B | $10.77B | 15.03% |
| 2000-12-31 | $2.38B | $15.38B | 15.45% |
| 2000-09-30 | $4.84B | $14.18B | 34.11% |
| 2000-06-30 | $4.51B | $18.70B | 24.13% |
| 2000-03-31 | $3.61B | $18.08B | 19.98% |
| 1999-12-31 | $3.05B | $18.63B | 16.35% |
| 1999-09-30 | $31.72B | $18.93B | 167.53% |
| 1999-06-30 | $31.79B | $14.42B | 220.47% |
| 1999-03-31 | $32.99B | $9.87B | 334.14% |
| 1998-12-31 | $33.89B | $4.73B | 716.97% |
| 1998-09-30 | $37.85B | $3.42B | 1107.20% |
| 1998-06-30 | $38.92B | $3.42B | 1138.62% |
| 1998-03-31 | $39.01B | $3.42B | 1141.23% |
| 1997-12-31 | $39.13B | $3.42B | 1144.59% |
| 1997-09-30 | $39.39B | $3.47B | 1135.92% |
| 1997-06-30 | $39.63B | $3.47B | 1143.01% |
| 1997-03-31 | $40.14B | $3.47B | 1157.61% |
| 1996-12-31 | $40.97B | $3.47B | 1181.46% |
| 1996-06-30 | $28.53B | $3.53B | 808.04% |
| 1996-03-31 | $28.47B | $3.53B | 806.40% |
| 1995-09-30 | $38.67B | $1.54B | 2516.84% |
| 1995-06-30 | $37.11B | $1.54B | 2415.36% |
| 1995-03-31 | $35.48B | $1.54B | 2309.72% |
| 1994-12-31 | $33.79B | $1.54B | 2199.32% |
| 1994-06-30 | $22.52B | $2.58B | 871.93% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.651B | $20.173B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |